Xellia Pharmaceuticals Receives US FDA Approval for Premixed Vancomycin Injection
COPENHAGEN, Denmark & BUFFALO GROVE, IL.--(BUSINESS WIRE)--Feb 19, 2019--Xellia Pharmaceuticals ('Xellia'), a global leader in the manufacturing of specialty anti-infective treatme…
